1. Home
  2. RYI vs PLRX Comparison

RYI vs PLRX Comparison

Compare RYI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation

RYI

Ryerson Holding Corporation

HOLD

Current Price

$26.38

Market Cap

843.2M

Sector

Industrials

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.28

Market Cap

93.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYI
PLRX
Founded
1842
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
843.2M
93.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RYI
PLRX
Price
$26.38
$1.28
Analyst Decision
Hold
Hold
Analyst Count
1
11
Target Price
$25.00
$3.79
AVG Volume (30 Days)
341.1K
1.1M
Earning Date
02-19-2026
11-06-2025
Dividend Yield
2.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,473,900,000.00
N/A
Revenue This Year
$0.38
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.18
$1.10
52 Week High
$27.41
$13.68

Technical Indicators

Market Signals
Indicator
RYI
PLRX
Relative Strength Index (RSI) 63.69 46.66
Support Level $24.75 $1.20
Resistance Level $26.79 $1.27
Average True Range (ATR) 0.81 0.06
MACD -0.06 0.02
Stochastic Oscillator 87.58 59.37

Price Performance

Historical Comparison
RYI
PLRX

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Share on Social Networks: